|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.560 USD | +4.71% |
|
+1.71% | +4.40% |
| 08-06 | B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating | MT |
| 08-06 | LifeMD, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Software & Technology Services
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 172M | - | - | - | ||
| 37.44B | |||||
| 12.99B | |||||
| 5.44B | |||||
| 2.49B | - | ||||
| 1.84B | - | - | - | - | - |
- Stock Market
- Stocks
- LFMD Stock
- Charts LifeMD, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
